Plaintiffs in a securities class action against Merck have reached a milestone in the Vioxx litigation saga -- one that makes yet another settlement much more likely. A federal judge in New Jersey has granted class certification in the eight-year-old case, which accuses Merck and certain executives of overstating the commercial promise of Vioxx despite its health risks.
Source: http://www.law.com/jsp/law/sign_me_in.jsp?article=http://www.americanlawyer.com/digestTAL.jsp?id=1202586781700&rss=newswire
bankruptcy lawyer bankruptcy lawyers best attorney business law
No comments:
Post a Comment